Study on Pembrolizumab Plus New Drugs for Treating Resectable Non-Small Cell Lung Cancer (NSCLC) | Clinical Trial

Study on Pembrolizumab Plus New Drugs for Treating Resectable Non-Small Cell Lung Cancer (NSCLC) | Clinical Trial | Right2Hope